These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11201362)

  • 1. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
    Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
    Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining trends in HTLV-I prevalence among blood donors in Japan.
    Yamaguchi K
    Intern Med; 2001 Jan; 40(1):1-2. PubMed ID: 11201361
    [No Abstract]   [Full Text] [Related]  

  • 3. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
    Satake M; Yamaguchi K; Tadokoro K
    J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan.
    Koga Y; Iwanaga M; Soda M; Inokuchi N; Sasaki D; Hasegawa H; Yanagihara K; Yamaguchi K; Kamihira S; Yamada Y
    J Med Virol; 2010 Apr; 82(4):668-74. PubMed ID: 20166187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of mother-to-child transmission of human T-lymphotropic virus type-I.
    Tsuji Y; Doi H; Yamabe T; Ishimaru T; Miyamoto T; Hino S
    Pediatrics; 1990 Jul; 86(1):11-7. PubMed ID: 2359666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HTLV-I carriers in ATL/L-nonendemic area--with reference to blood transfusions].
    Sakuma M; Takiguchi T; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1989 Aug; 52(5):869-79. PubMed ID: 2588946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK; Bhatti FA; Salamat N
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T lymphotropic virus I in Indonesia. Very low seroprevalence in the Jakarta area: antibodies in healthy blood donors and in various nonhematological diseases.
    Tanggo Y; Gultom SP; Simanjuntak T; Sibuea WH; Matsuzaki H; Yamaguchi K
    Intervirology; 2000; 43(2):77-9. PubMed ID: 10971124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening of sera from the adult populations of some USSR regions for antibodies to the human T-cell leukemia virus type I (HTLV-I)].
    Seniuta NB; Iakovleva LS; Stepina VN; Buachidze LN; Gurova EP; Kologrivova ZA; Kindiakov VM; Gurtsevich VE
    Vopr Virusol; 1990; 35(4):309-12. PubMed ID: 2256315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia.
    Arif M; Ramia S
    Ann Trop Med Parasitol; 1998 Apr; 92(3):305-9. PubMed ID: 9713546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina].
    Gallego S; Maturano E; Recalde A; Gastaldello R; Sileoni S; Bepre H; Medeot S
    Rev Argent Microbiol; 2001; 33(3):182-6. PubMed ID: 11594010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana.
    Armah HB; Narter-Olaga EG; Adjei AA; Asomaning K; Gyasi RK; Tettey Y
    J Med Microbiol; 2006 Jun; 55(Pt 6):765-770. PubMed ID: 16687597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.
    Yoshida N; Chihara D
    Curr Treat Options Oncol; 2015 Feb; 16(2):7. PubMed ID: 25762122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
    Mizokami T; Okamura K; Ikenoue H; Sato K; Kuroda T; Maeda Y; Fujishima M
    Thyroid; 1994; 4(4):415-9. PubMed ID: 7711504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.